| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Revenue | 1,137 | 1,241 | 1,193 | 1,030 |
| Cost of sales | 530 | 528 | 509 | 492 |
| Gross profit | 607 | 713 | 684 | - |
| Research and development | 89 | 92 | 94 | 87 |
| Marketing, selling and administrative | 351 | 400 | 341 | 323 |
| Amortization of intangible assets | 140 | 136 | 128 | 133 |
| Asset impairment, restructuring and other special charges | 25 | 1 | 9 | 17 |
| Goodwill impairment | - | - | - | 0 |
| Gain on divestiture | 0 | - | - | 640 |
| Interest expense, net of capitalized interest | - | - | - | 58 |
| Other expense, net | - | - | - | -1 |
| Interest expense, net of capitalized interest | 52 | 48 | 40 | - |
| Costs, expenses and other | - | - | - | 471 |
| Other expense, net | 0 | -11 | -12 | - |
| (loss) income before income taxes | -50 | 25 | 60 | 559 |
| Income tax (benefit) expense | -16 | 14 | -7 | 195 |
| Net (loss) income | -34 | 11 | 67 | 364 |
| Basic (in shares) | 496,800,000 | 496,600,000 | 495,100,000 | 494,300,000 |
| Basic (usd per share) | -0.07 | 0.02 | 0.14 | 0.74 |
| Diluted (in shares) | 496,800,000 | 500,100,000 | 499,100,000 | 497,700,000 |
| Diluted (usd per share) | -0.07 | 0.02 | 0.13 | 0.73 |
Elanco Animal Health Inc (ELAN)
Elanco Animal Health Inc (ELAN)